From Validation to Differentiation: R&D’s Evidence Advantage

Rising regulatory scrutiny and more informed consumers are raising the bar for product credibility, making evidence a critical driver of success, scalability, and differentiation. Across industries, Research & Development teams are moving beyond validation as a final step and embedding structured, data-driven evidence throughout the development lifecycle to improve alignment, reduce rework, and strengthen outcomes. 

On June 17, join our “In Conversation Series” with Everest Group’s Aarthi Janakiraman and the Founder and CEO of Benefic Nutrition, Dr. Yashawant Kumar, to explore how leading R&D teams are building evidence upstream. The discussion will highlight how early definition of success criteria, integrated data strategies, and outcome-linked approaches can enhance credibility, accelerate decision-making, and enable globally scalable innovation. 

 
During this LinkedIn Live “In Conversation Series,” we’ll discuss:

• How should R&D teams design evidence strategies early in development to ensure products meet both global and local market requirements? 
• What level and type of validation are required to differentiate products without overinvesting evidence? 
• How can organizations build scalable processes to generate, use, and reuse evidence across products, markets, and categories?